Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML

Zhihong Zeng, Dos D. Sarbassov, Ismael J. Samudio, Karen W L Yee, Mark F. Munsell, C. Ellen Jackson, Francis J. Giles, David M. Sabatini, Michael Andreeff, Marina Konopleva*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

291 Scopus citations

Fingerprint

Dive into the research topics of 'Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds